Close Menu

NEW YORK – Cancer Genetics reported on Monday that its fourth quarter revenues grew about 12 percent year over year, which the firm noted was  partially the result of the adoption of the new ASC 606 revenue recognition standard and the variability in project start and end times at the individual contract level in the firm's discovery services business unit.

For the three months ended Dec. 31, 2019, the firm reported total revenues from continuing operations of $1.9 million, up from $1.7 million in the fourth quarter of 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.